Stock Groups

EU drugs regulator says to decide on Pfizer vaccine booster in early October By Reuters

by Mike Robinson

[ad_1]

© Reuters

(Reuters) – The European Medicines Agency (EMA) will likely decide in early October whether to endorse a third dose of the Pfizer-BioNTech COVID-19 vaccine to be given half a year after the initial two-shot course.

Marco Cavaleri from the European Medicines Agency (EMA), head of vaccines strategy said Thursday that the results of this evaluation are expected in October, unless supplementary data is required.

Reuters had reported earlier that the EMA is expected to conclude on booster doses within October.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]